Navigation Links
Nuvelo Announces Presentation on NU206 at 2007 American Association,for Cancer Research Annual Meeting

SAN CARLOS, Calif., April 04, 2007 /PRNewswire-FirstCall/ -- Nuvelo, Inc. today announced that preclinical data evaluating the mechanism of action and role of NU206 (R-Spondin1) as a specific and potent stimulator of the gastrointestinal (GI) epithelial cells will be presented in an educational session at the 2007 American Association for Cancer Research (AACR) Annual Meeting taking place at the Los Angeles Convention Center in Los Angeles, CA, April 14-18, 2007.

    The presentation details are as follows:

          Date/Time: Saturday, April 14, 2007, 8:00-10:00 a.m. PDT

          Location: Room 403 A-B, Los Angeles Convention Center

          Session/Abstract Title: Therapeutic Cancer Targets in the Wnt

          Pathway/R-Spondin, novel regulators of the Wnt/b-catenin signaling


    About NU206

NU206, also known as human R-spondin1, is a recombinant, secreted protein that has the potential to act as a potent and highly specific growth factor of GI epithelial cells. In early animal model studies, NU206 promoted growth and repair of these tissues in models of radiation treatment or chemotherapy, as well as in animal models of inflammatory bowel disease and short bowel syndrome. A publication in the August 2005 issue of Science described results from studies in animal models of mucositis, where NU206 was shown to diminish symptoms of mucositis, including diarrhea and weight loss.

About Nuvelo and Kirin's Joint Collaborative Effort

Scientists from Nuvelo and Kirin worked together to identify and characterize NU206 as part of a collaboration focused on the discovery of novel, secreted proteins. NU206 is the first compound to enter preclinical studies from this program. Nuvelo signed a collaboration agreement with Kirin in April 2005 to develop NU206. Under the agreement, Nuvelo leads worldwide development, manufacturing and commercialization and all operating expenses and p
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
3. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
4. Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
5. Nuvelo Announces Presentation on rNAPc2 at American College of Cardiology 56th Annual Scientific Session
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:7/29/2015)... July 29, 2015  Ortho-Clinical Diagnostics, Inc. (OCD) today ... development. The assays address a range of important tests ... cardiac troponin I. The scientific posters will be delivered ... Meeting to be held July 26 - 30 in ... "Ortho Clinical Diagnostics is emerging stronger than ever since ...
(Date:7/29/2015)... , July 27, 2015 Research and ... of the "Global Neurostimulation Devices Market 2015" ... analysts forecast the global neurostimulation devices market to ... period 2014-2019. The report, Global Neurostimulation ... an in-depth market analysis with inputs from industry ...
(Date:7/29/2015)... , July 29, 2015 The Judicial ... this week about whether to centralize Inferior vena cava ... competing IVC manufacturer, Cook Medical, have already been centralized ... devices implanted in patients at risk for a pulmonary ... from traveling to the lungs. Claims against Bard and ...
Breaking Medicine Technology:Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3Global Neurostimulation Devices Market 2015-2019 2IVC filter litigation continues; law firm provides free information to IVC filter patients 2
... A new study published online today ... NEJM) shows bevacizumab (Avastin) is as effective as ranibizumab ... treating age-related macular degeneration (AMD). The ... Trials" (CATT) study, a pioneering comparative effectiveness trial made ...
... 2011 PharmaNet Development Group, Inc., a leading provider ... and medical device companies, announced today that Valerie Palumbo ... Quality Assurance. "We are very pleased ... President, PharmaNet Development Group. "Valerie brings deep experience in ...
Cached Medicine Technology:Cleveland Clinic-Led Study Finds Bevacizumab as Effective as FDA-Approved Ranibizumab in Treating Macular Degeneration 2Cleveland Clinic-Led Study Finds Bevacizumab as Effective as FDA-Approved Ranibizumab in Treating Macular Degeneration 3Cleveland Clinic-Led Study Finds Bevacizumab as Effective as FDA-Approved Ranibizumab in Treating Macular Degeneration 4
(Date:7/29/2015)... ... 29, 2015 , ... We are privileged to announce that U.S. News & World Report ... best ophthalmology hospital in the nation for 2015-2016. This marks the 21st consecutive year that ... , “It is an honor to be included in the top 10 ophthalmology hospitals by ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by a successful ... Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine expert in ... financial need. , “We are thrilled for this opportunity to offer prolotherapy treatments ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... first two patients in a Clinical Performance Study for the Invisiport at Wheaton ... and 6 French catheter options, offers a less invasive, patient-friendly alternative to traditional ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... the Judicial Panel on Multidistrict Litigation (JPML), according to court documents.* Attorneys handling ... their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical ...
(Date:7/29/2015)... ... July 29, 2015 , ... The Woodlands and Spring Fit Body Boot Camps ... worthy charitable causes each month. The new system will track each time a client ... In at each facility, the boot camps will donate 20 cents to a selected ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3
... High-resolution images from a laser-based tool developed at Duke ... of skin cancer, while potentially saving thousands of lives and ... The tool probes skin cells using two lasers to pump ... pointer, into a suspicious mole. Scientists analyze the way the ...
... team of neuroscientists at Cold Spring Harbor Laboratory (CSHL), Brookhaven ... evidence suggesting that a previously overlooked portion of the brain ... In two rat models of human depression, the scientists ... central brain called the lateral habenula (LHb) are hyperactive. ...
... WEDNESDAY, Feb. 23 (HealthDay News) -- Smoking increases the ... study shows. U.S. researchers conducted tests on human ... cigarette smoke suppresses a protein that causes the natural ... patients. The study appears online ahead of print ...
... By Maureen Salamon HealthDay Reporter , ... for chronic low back pain -- an increasingly controversial ... 20 years -- leads to higher rates of permanent ... non-surgically, a new study finds. Researchers randomly selected ...
... In a finding that may potentially improve survival from ... whole blood may have a shelf life well beyond ... "We have found that whole blood retains its clotting ... the study leader, David Jobes, M.D., a cardiothoracic anesthesiologist ...
... HealthDay Reporter , TUESDAY, Feb. 22 (HealthDay News) -- ... brain closest to the phone,s antenna, but experts say they ... health risk. "We don,t know whether this is detrimental ... don,t know one way or the other," said Dr. Nora ...
Cached Medicine News:Health News:Lasers ID deadly skin cancer better than doctors 2Health News:Lasers ID deadly skin cancer better than doctors 3Health News:Neuroscientists find overlooked brain area is an important locus of depression 2Health News:Neuroscientists find overlooked brain area is an important locus of depression 3Health News:Cigarette Smoke Fuels Mucus Production in People With Bronchitis 2Health News:Spinal Fusion Surgery May Leave Some Back Pain Patients Worse Off: Study 2Health News:Spinal Fusion Surgery May Leave Some Back Pain Patients Worse Off: Study 3Health News:Whole fresh blood for transfusions may have a longer shelf life than now assumed 2Health News:Cell Phones Affect Areas of the Brain, Study Shows 2Health News:Cell Phones Affect Areas of the Brain, Study Shows 3
... and ease of the World's First Hand-Held ... for accuracy, reliability and performance Share the ... With no wires to limit, you can ... measurement range and advanced measurement modes. ...
Introducing the Guidant HEARTSTRING Proximal Seal System. A surgically intuitive system that meets the challenge of clampless hemostasis with a design that is elegant in its simplicity and profound i...
... The Given system, developed by Given Imaging of ... size of a grape. Weighing in at only ... camera, 4 LED lights, battery and radio transmitter ... resistant to digestive enzymes. Internal gastric images are ...
... CO2 TMR technology is an ... diffuse vessels with poor targets. ... between surgical suites, the CO2 ... surgeon to make timely operative ...
Medicine Products: